157 related articles for article (PubMed ID: 10423051)
1. Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation.
Busca A; Saroglia EM; Giacchino M; Vai S; Vassallo E; Fagioli F; Linari A; Dotti G; Miniero R; Madon E
Support Care Cancer; 1999 Jul; 7(4):253-9. PubMed ID: 10423051
[TBL] [Abstract][Full Text] [Related]
2. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Sparrelid E; Hägglund H; Remberger M; Ringdén O; Lönnqvist B; Ljungman P; Andersson J
Bone Marrow Transplant; 1998 Oct; 22(8):795-800. PubMed ID: 9827978
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.
Saavedra S; Jarque I; Sanz GF; Moscardó F; Jiménez C; Martín G; Plumé G; Regadera A; Martínez J; De La Rubia J; Acosta B; Pemán J; Pérez-Bellés C; Gobernado M; Sanz MA
Clin Microbiol Infect; 2002 Nov; 8(11):725-33. PubMed ID: 12445010
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation.
Dini G; Floris R; Pession A; Manfredini L; Dallorso S; Lanino E; Garaventa A; Miano M; Kotitsa Z; Rondelli R
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():121-8. PubMed ID: 8932813
[TBL] [Abstract][Full Text] [Related]
7. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
8. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
9. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
Lewis ID; DeFor T; Weisdorf DJ
Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study.
Elishoov H; Or R; Strauss N; Engelhard D
Medicine (Baltimore); 1998 Mar; 77(2):83-101. PubMed ID: 9556701
[TBL] [Abstract][Full Text] [Related]
11. Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience.
Dell'Orto M; Rovelli A; Barzaghi A; Valsecchi MG; Silvestri D; Giltri G; Balduzzi A; Biagi E; Arrigo C; Rossi MR; Masera G; Uderzo C
Pediatr Hematol Oncol; 1997; 14(4):335-47. PubMed ID: 9211538
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
13. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
[TBL] [Abstract][Full Text] [Related]
14. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.
Ochs L; Shu XO; Miller J; Enright H; Wagner J; Filipovich A; Miller W; Weisdorf D
Blood; 1995 Nov; 86(10):3979-86. PubMed ID: 7579369
[TBL] [Abstract][Full Text] [Related]
15. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
16. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
17. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
19. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.
Gustafsson A; Remberger M; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 May; 25(10):1059-65. PubMed ID: 10828866
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]